INSR_MOUSE - dbPTM
INSR_MOUSE - PTM Information in dbPTM
Basic Information of Protein
UniProt ID INSR_MOUSE
UniProt AC P15208
Protein Name Insulin receptor
Gene Name Insr
Organism Mus musculus (Mouse).
Sequence Length 1372
Subcellular Localization Cell membrane
Single-pass type I membrane protein.
Protein Description Receptor tyrosine kinase which mediates the pleiotropic actions of insulin. Binding of insulin leads to phosphorylation of several intracellular substrates, including, insulin receptor substrates (IRS1, 2, 3, 4), SHC, GAB1, CBL and other signaling intermediates. Each of these phosphorylated proteins serve as docking proteins for other signaling proteins that contain Src-homology-2 domains (SH2 domain) that specifically recognize different phosphotyrosine residues, including the p85 regulatory subunit of PI3K and SHP2. Phosphorylation of IRSs proteins lead to the activation of two main signaling pathways: the PI3K-AKT/PKB pathway, which is responsible for most of the metabolic actions of insulin, and the Ras-MAPK pathway, which regulates expression of some genes and cooperates with the PI3K pathway to control cell growth and differentiation. Binding of the SH2 domains of PI3K to phosphotyrosines on IRS1 leads to the activation of PI3K and the generation of phosphatidylinositol-(3, 4, 5)-triphosphate (PIP3), a lipid second messenger, which activates several PIP3-dependent serine/threonine kinases, such as PDPK1 and subsequently AKT/PKB. The net effect of this pathway is to produce a translocation of the glucose transporter SLC2A4/GLUT4 from cytoplasmic vesicles to the cell membrane to facilitate glucose transport. Moreover, upon insulin stimulation, activated AKT/PKB is responsible for: anti-apoptotic effect of insulin by inducing phosphorylation of BAD; regulates the expression of gluconeogenic and lipogenic enzymes by controlling the activity of the winged helix or forkhead (FOX) class of transcription factors. Another pathway regulated by PI3K-AKT/PKB activation is mTORC1 signaling pathway which regulates cell growth and metabolism and integrates signals from insulin. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 thereby activating mTORC1 pathway. The Ras/RAF/MAP2K/MAPK pathway is mainly involved in mediating cell growth, survival and cellular differentiation of insulin. Phosphorylated IRS1 recruits GRB2/SOS complex, which triggers the activation of the Ras/RAF/MAP2K/MAPK pathway. In addition to binding insulin, the insulin receptor can bind insulin-like growth factors (IGFI and IGFII). When present in a hybrid receptor with IGF1R, binds IGF1 (By similarity)..
Protein Sequence MGFGRGCETTAVPLLVAVAALLVGTAGHLYPGEVCPGMDIRNNLTRLHELENCSVIEGHLQILLMFKTRPEDFRDLSFPKLIMITDYLLLFRVYGLESLKDLFPNLTVIRGSRLFFNYALVIFEMVHLKELGLYNLMNITRGSVRIEKNNELCYLATIDWSRILDSVEDNYIVLNKDDNEECGDVCPGTAKGKTNCPATVINGQFVERCWTHSHCQKVCPTICKSHGCTAEGLCCHKECLGNCSEPDDPTKCVACRNFYLDGQCVETCPPPYYHFQDWRCVNFSFCQDLHFKCRNSRKPGCHQYVIHNNKCIPECPSGYTMNSSNLMCTPCLGPCPKVCQILEGEKTIDSVTSAQELRGCTVINGSLIINIRGGNNLAAELEANLGLIEEISGFLKIRRSYALVSLSFFRKLHLIRGETLEIGNYSFYALDNQNLRQLWDWSKHNLTITQGKLFFHYNPKLCLSEIHKMEEVSGTKGRQERNDIALKTNGDQASCENELLKFSFIRTSFDKILLRWEPYWPPDFRDLLGFMLFYKEAPYQNVTEFDGQDACGSNSWTVVDIDPPQRSNDPKSQTPSHPGWLMRGLKPWTQYAIFVKTLVTFSDERRTYGAKSDIIYVQTDATNPSVPLDPISVSNSSSQIILKWKPPSDPNGNITHYLVYWERQAEDSELFELDYCLKGLKLPSRTWSPPFESDDSQKHNQSEYDDSASECCSCPKTDSQILKELEESSFRKTFEDYLHNVVFVPRPSRKRRSLEEVGNVTATTLTLPDFPNVSSTIVPTSQEEHRPFEKVVNKESLVISGLRHFTGYRIELQACNQDSPDERCSVAAYVSARTMPEAKADDIVGPVTHEIFENNVVHLMWQEPKEPNGLIVLYEVSYRRYGDEELHLCVSRKHFALERGCRLRGLSPGNYSVRVRATSLAGNGSWTEPTYFYVTDYLDVPSNIAKIIIGPLIFVFLFSVVIGSIYLFLRKRQPDGPMGPLYASSNPEYLSASDVFPSSVYVPDEWEVPREKITLLRELGQGSFGMVYEGNAKDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSHLRSLRPDAENNPGRPPPTLQEMIQMTAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTASSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDPPDNCPERLTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSFFYSEENKAPESEELEMEFEDMENVPLDRSSHCQREEAGGREGGSSLSIKRTYDEHIPYTHMNGGKKNGRVLTLPRSNPS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
43N-linked_GlycosylationPGMDIRNNLTRLHEL
CCCCCCCCHHHHHHH
32.70-
52N-linked_GlycosylationTRLHELENCSVIEGH
HHHHHHCCCEEEECE
35.67-
105N-linked_GlycosylationSLKDLFPNLTVIRGS
HHHHHCCCCEEEECC
40.80-
138N-linked_GlycosylationLGLYNLMNITRGSVR
CCHHHHHCCCCCCEE
35.33-
242N-linked_GlycosylationCHKECLGNCSEPDDP
ECHHHHCCCCCCCCC
17.13-
282N-linked_GlycosylationFQDWRCVNFSFCQDL
CCCEEEEEEHHHCCC
30.39-
284PhosphorylationDWRCVNFSFCQDLHF
CEEEEEEHHHCCCCH
21.6528418008
322N-linked_GlycosylationCPSGYTMNSSNLMCT
CCCCCEECCCCCEEC
34.19-
364N-linked_GlycosylationLRGCTVINGSLIINI
HCCCEEECCEEEEEE
29.66-
400PhosphorylationGFLKIRRSYALVSLS
HHHHHHHHHHHHHHH
12.62-
401PhosphorylationFLKIRRSYALVSLSF
HHHHHHHHHHHHHHH
11.35-
407PhosphorylationSYALVSLSFFRKLHL
HHHHHHHHHHHHHCC
18.16-
419PhosphorylationLHLIRGETLEIGNYS
HCCCCCCEEEECCEE
32.3024719451
424N-linked_GlycosylationGETLEIGNYSFYALD
CCEEEECCEEEEEEC
34.63-
426PhosphorylationTLEIGNYSFYALDNQ
EEEECCEEEEEECCC
18.7724719451
445N-linked_GlycosylationLWDWSKHNLTITQGK
HHHHHHCCEEEECCE
42.4919656770
447PhosphorylationDWSKHNLTITQGKLF
HHHHCCEEEECCEEE
27.56-
457PhosphorylationQGKLFFHYNPKLCLS
CCEEEEECCHHHHHH
28.18-
541N-linked_GlycosylationYKEAPYQNVTEFDGQ
CCCCCCCCCEEECCC
36.51-
635N-linked_GlycosylationLDPISVSNSSSQIIL
CCCEECCCCCCEEEE
43.70-
653N-linked_GlycosylationPPSDPNGNITHYLVY
CCCCCCCCEEEEEEE
42.50-
700N-linked_GlycosylationSDDSQKHNQSEYDDS
CCCHHCCCHHHCCCC
54.85-
717PhosphorylationECCSCPKTDSQILKE
HHCCCCCCHHHHHHH
26.4828059163
759N-linked_GlycosylationRSLEEVGNVTATTLT
CCHHHHCCEEEEEEE
32.89-
772N-linked_GlycosylationLTLPDFPNVSSTIVP
EECCCCCCCCCCCCC
46.42-
910N-linked_GlycosylationLRGLSPGNYSVRVRA
CCCCCCCCEEEEEEE
29.32-
923N-linked_GlycosylationRATSLAGNGSWTEPT
EEEECCCCCCCCCCE
35.40-
989PhosphorylationYASSNPEYLSASDVF
CCCCCCCCCCHHHCC
13.7622817900
1001PhosphorylationDVFPSSVYVPDEWEV
HCCCCCCCCCCCCCC
14.2820332342
1012UbiquitinationEWEVPREKITLLREL
CCCCCHHHHHHHHHH
42.1222790023
1012UbiquitinationEWEVPREKITLLREL
CCCCCHHHHHHHHHH
42.1222790023
1037UbiquitinationGNAKDIIKGEAETRV
CCHHHHHCCCCEEEE
51.5422790023
1037UbiquitinationGNAKDIIKGEAETRV
CCHHHHHCCCCEEEE
51.5422790023
1047UbiquitinationAETRVAVKTVNESAS
CEEEEEEEECCCCCC
36.7022790023
1047UbiquitinationAETRVAVKTVNESAS
CEEEEEEEECCCCCC
36.7022790023
1052PhosphorylationAVKTVNESASLRERI
EEEECCCCCCHHHHH
20.25-
1054PhosphorylationKTVNESASLRERIEF
EECCCCCCHHHHHHH
36.92-
1122PhosphorylationNPGRPPPTLQEMIQM
CCCCCCCCHHHHHHH
47.0128059163
1171PhosphorylationKIGDFGMTRDIYETD
EECCCCCCCCEEECC
26.1023375375
1175PhosphorylationFGMTRDIYETDYYRK
CCCCCCEEECCCCCC
19.648940173
1177PhosphorylationMTRDIYETDYYRKGG
CCCCEEECCCCCCCC
16.6022499769
1179PhosphorylationRDIYETDYYRKGGKG
CCEEECCCCCCCCCC
16.7625521595
1180PhosphorylationDIYETDYYRKGGKGL
CEEECCCCCCCCCCC
14.5225521595
1185UbiquitinationDYYRKGGKGLLPVRW
CCCCCCCCCCCCEEE
55.8622790023
1185UbiquitinationDYYRKGGKGLLPVRW
CCCCCCCCCCCCEEE
55.8622790023
1337PhosphorylationAGGREGGSSLSIKRT
CCCCCCCCCCEEEEE
38.6723737553
1338PhosphorylationGGREGGSSLSIKRTY
CCCCCCCCCEEEEEC
29.4327180971
1340PhosphorylationREGGSSLSIKRTYDE
CCCCCCCEEEEECCC
28.1925521595
1344PhosphorylationSSLSIKRTYDEHIPY
CCCEEEEECCCCCCC
30.2622817900
1345PhosphorylationSLSIKRTYDEHIPYT
CCEEEEECCCCCCCC
24.3022817900
1351PhosphorylationTYDEHIPYTHMNGGK
ECCCCCCCCCCCCCC
14.5222817900
1352PhosphorylationYDEHIPYTHMNGGKK
CCCCCCCCCCCCCCC
14.8623684622
1365PhosphorylationKKNGRVLTLPRSNPS
CCCCEEEECCCCCCC
31.6821454597
1369PhosphorylationRVLTLPRSNPS----
EEEECCCCCCC----
51.6729514104

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
-KUbiquitinationE3 ubiquitin ligaseFbxo2Q80UW2
PMID:27932386

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of INSR_MOUSE !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of INSR_MOUSE !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SRBS1_MOUSESorbs1physical
9447983
SH2B2_MOUSESh2b2physical
10196204
FLOT1_MOUSEFlot1physical
16455755
CAV3_MOUSECav3physical
16455755
GRB10_MOUSEGrb10physical
9062339
PLAK_MOUSEJupphysical
24567360
AKT1_MOUSEAkt1physical
19122674
SRC_MOUSESrcphysical
19122674
ARRB2_MOUSEArrb2physical
19122674
CLK1_HUMANCLK1physical
26496610
PDIA3_HUMANPDIA3physical
26496610
IGF1R_HUMANIGF1Rphysical
26496610
FAF2_HUMANFAF2physical
26496610
NSF1C_HUMANNSFL1Cphysical
26496610
UBE2O_HUMANUBE2Ophysical
26496610

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of INSR_MOUSE

loading...

Related Literatures of Post-Translational Modification
N-linked Glycosylation
ReferencePubMed
"Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins.";
Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.;
Nat. Biotechnol. 27:378-386(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-445, AND MASSSPECTROMETRY.
"The mouse C2C12 myoblast cell surface N-linked glycoproteome:identification, glycosite occupancy, and membrane orientation.";
Gundry R.L., Raginski K., Tarasova Y., Tchernyshyov I.,Bausch-Fluck D., Elliott S.T., Boheler K.R., Van Eyk J.E.,Wollscheid B.;
Mol. Cell. Proteomics 8:2555-2569(2009).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-445, AND MASSSPECTROMETRY.

TOP